Dr Reddy's launches generic drug to treat multiple sclerosis in US

The company's product is a therapeutic equivalent generic version of Biogen's Tecfidera delayed-release capsules, the Hyderabad-based drug firm said in a statement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2GeDvWJ
via IFTTT